ReviewProgress in the chemistry of organic natural products2025
Biologically Active Compounds of Malaysian Medicinal and Aromatic Plants.
Review in Progress in the chemistry of organic natural products, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This contribution provides a comprehensive review of the biologically active compounds present in 21 high-value medicinal and aromatic plant species from Malaysia, with a particular focus on their phytochemical diversity and biological activities. Several plants, including well-known species such as Eurycoma longifolia, Andrographis paniculata, Morinda citrifolia, Centella asiatica, and Moringa oleifera, have been designated as high-priority herbal products under Malaysia's National Key Economic Area (NKEA) in the Eleventh Malaysia Plan (RMK-11). Their significance extends beyond traditional uses in herbal medicine, as they are being recognized increasingly for their potential to contribute to the national economy and modern healthcare solutions. The compilation provided describes the pharmacological properties of these plants, highlighting their anti-inflammatory, antioxidant, antimicrobial, and cytotoxic activities, among others. Additionally, the aromatic plants Clinacanthus nutans, Cananga odorata, Citrus hystrix, and Polygonum minus are included in terms of their bioactive compounds produced and their potential therapeutic and industrial applications. By highlighting the relevant current research, this compilation aims to provide valuable insight for researchers, policymakers, and industry stakeholders, in terms of enhancing the understanding of both the therapeutic potential of these plants and their possible future contributions to healthcare and sustainable economic development.
Indexed as
Identifiers
40652426What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.